LSBC, in partnership with Biotech Primer, was pleased to present BioBasics 201: Targeted Biologics for the Non-Scientist, an intensive, two-day course focused on vaccines, cell therapies, gene therapies, therapeutic antibodies, and RNA-based drugs. Biopharma’s inspiration for the development of targeted biologics was our own human immune system, so we began with an in-depth explanation of immunology. The course then focused on the science, challenges, and medical promise of next generation targeted biologics. BioBasics 201 was designed for the non-scientist who had taken BioBasics 101 or for those who understood the basics of DNA, RNA, proteins, and cell signaling. Taught by industry experts who explained how these complex drugs work in a simple, engaging manner.
Five Takeaways:
1. Understood the mechanisms used by the human body to protect itself against disease.
2. Fluency in vaccine platforms, how each protected against disease including Covid-19.
3. Rational of therapeutic antibody mechanisms of action, including monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, checkpoint inhibitors.
4. Compared and contrasted types of DNA- and RNA-based therapies and how each cured disease.
5. Increased knowledge of cell therapies, including all variations of CAR-based therapies
